What to Expect When Starting Levothyroxine
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Introduction
Levothyroxine (brand names Synthroid, Levoxyl, Tirosint, Euthyrox) is a synthetic form of the thyroid hormone thyroxine (T4), and it is the most prescribed medication in the United States, with over 100 million prescriptions dispensed annually [1][2]. It is the standard treatment for hypothyroidism — a condition in which the thyroid gland does not produce enough hormone — and for thyroid hormone replacement after thyroidectomy or radioactive iodine treatment [1].
Unlike many medications that produce noticeable effects within hours or days, levothyroxine has a uniquely slow onset. T4 has a half-life of approximately 6-7 days, which means it takes 4-6 weeks for blood levels to reach a new steady state after starting or changing a dose [1][2]. The American Thyroid Association (ATA) guidelines recommend checking TSH levels 4-6 weeks after any dose adjustment, as earlier testing will not reflect the true steady-state effect [3]. This slow pharmacokinetic profile means that patience and consistent daily dosing are critical to successful treatment.
This guide explains the timeline of what to expect when starting levothyroxine, so you understand why improvement is gradual and why multiple dose adjustments are common. Most patients require 1-3 dose titrations over 3-6 months before reaching their optimal dose [3][5]. Always follow your healthcare provider's dosing instructions and attend follow-up lab appointments on schedule.
Week-by-week timeline
Starting Treatment
Your provider has selected a starting dose based on your weight, age, severity of hypothyroidism, and cardiovascular status [1][3]. For most adults, the full replacement dose is approximately 1.6 mcg/kg/day, but providers typically start lower and titrate up [3]. Younger, healthy patients may start near the full dose, while older patients or those with cardiac disease start at 25-50 mcg to avoid stressing the cardiovascular system [1][5]. During these first two weeks, levothyroxine is building up in your system — T4 has a half-life of ~7 days, so it takes approximately 5 half-lives (35 days) to reach steady state [2]. You will likely not feel different yet.
- Little to no noticeable change in symptoms yet
- Possibly very mild improvement in energy in some patients
- Most patients feel the same as before starting treatment
- No significant side effects expected at appropriate starting doses
Early Response
Some patients begin noticing subtle improvements as T4 levels rise toward normal. Energy, mental clarity, and cold tolerance may begin to improve modestly [2]. Your body is converting T4 to the more active T3 hormone in peripheral tissues, and cellular metabolic processes are gradually normalizing [5]. However, you are not yet at pharmacokinetic steady state, and TSH testing at this point would not reflect the medication's full effect [3].
- Slight improvement in energy levels and daytime alertness
- Feeling less cold than before
- Brain fog beginning to lift — improved concentration and memory
- Possible mild headache as metabolic rate adjusts
- Subtle improvement in mood
First Lab Check
Your provider will check your TSH level at 6-8 weeks — this is the standard timepoint recommended by the ATA because blood levels have now reached steady state at the current dose [3]. The target TSH for most adults is 0.5-2.5 mU/L, though this varies by age and clinical context [3][5]. Based on results, your provider will adjust the dose — increases or decreases are typically made in 12.5-25 mcg increments [1]. It is very common to need one or more adjustments; finding the right dose is a process of guided titration, not guesswork.
- Noticeable improvement in energy, alertness, and exercise tolerance
- Reduced hair shedding (if it was a hypothyroid symptom) or temporary increased shedding (telogen effluvium — self-resolving)
- Improved mood and reduced depression symptoms
- Less dry skin and improved skin quality
- Possible temporary adjustment symptoms as dose is optimized
Dose Optimization
It typically takes 2-3 dose adjustments, each followed by a 6-8 week TSH check, to find your optimal dose [3][5]. Once your TSH is in the target range and you feel well symptomatically, your dose will be maintained long-term with annual monitoring. A study of levothyroxine dose stability found that approximately 30% of patients require dose changes over time due to weight changes, aging, pregnancy, or changes in concurrent medications [7]. The ATA recommends annual TSH monitoring once the dose is stable, and re-checking 6 weeks after any significant life change [3].
- Symptoms of hypothyroidism significantly improved or fully resolved
- Normal energy levels restored — able to exercise and function normally
- Improved skin, hair, and nail quality over weeks to months
- Weight stabilization (not dramatic loss, but resolution of hypothyroid-related fluid retention and metabolic slowing)
- Improved cholesterol levels (hypothyroidism raises LDL)
- Normalized bowel function
When to call your doctor
Contact your healthcare provider if you experience:
- Chest pain, rapid or irregular heartbeat, or shortness of breath — may indicate overreplacement (iatrogenic hyperthyroidism), particularly dangerous in patients with coronary artery disease [1][3]
- Signs of excessive thyroid hormone: persistent sweating, tremors, severe anxiety, unexplained rapid weight loss, diarrhea, heat intolerance — these suggest the dose is too high [1][2]
- Severe headache, significant mood changes, or new onset of depression or anxiety [1]
- Signs of allergic reaction to the medication or its inactive ingredients (fillers, dyes) — consider switching formulations if sensitivity is suspected [1]
- You are pregnant or planning to become pregnant — levothyroxine dose requirements increase by 30-50% during pregnancy, and inadequate thyroid hormone can affect fetal neurodevelopment [1][3]
- Any new medication is started — many drugs interact with levothyroxine absorption or metabolism, including calcium, iron, PPIs, estrogens, and anticonvulsants [1][5]
- Persistent fatigue, weight gain, or other hypothyroid symptoms despite treatment — may indicate malabsorption, inconsistent dosing, or need for dose adjustment [3]
- Bone pain or concerns about osteoporosis — chronic overreplacement (suppressed TSH) can reduce bone density, particularly in postmenopausal women [1][8]
Tips for getting started
Take levothyroxine first thing in the morning on an empty stomach, 30-60 minutes before breakfast, coffee, or other medications [1][3]. This timing is critical for optimal absorption — studies show that taking levothyroxine with food reduces absorption by approximately 40%, and coffee specifically reduces absorption by up to 30% [6]. The ATA guidelines emphasize the importance of consistent, fasting administration for reliable dosing [3].
Do not take levothyroxine within 4 hours of calcium supplements, iron supplements, antacids (containing aluminum or magnesium), proton pump inhibitors, or cholestyramine — all of these significantly reduce levothyroxine absorption [1][5]. If you take any of these, create a clear time separation in your daily schedule. Fiber supplements should also be separated by several hours.
Be consistent with the manufacturer/brand you use. Although generic levothyroxine is FDA-approved as bioequivalent, small differences in bioavailability between manufacturers (the FDA allows a range of 95-105% of stated potency) can be clinically significant for a narrow therapeutic index drug like levothyroxine [1][3]. The ATA recommends that if you switch between brands or between brand and generic, your TSH should be rechecked in 6 weeks [3]. Tirosint (a soft-gel capsule formulation) may offer more consistent absorption for patients with GI absorption issues [5].
Store at room temperature away from moisture and heat. If you miss a dose entirely, take it as soon as you remember the same day. If you miss a full day, it is generally safe to take two doses the next morning, as the long half-life of T4 provides a buffer against single missed doses [2][3]. However, do not make a habit of doubling up — consistency is key.
Frequently asked questions
More about Levothyroxine
References
- [Regulatory] Levothyroxine Sodium FDA Prescribing Information. AbbVie. Revised 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021342s038lbl.pdf Accessed 2025-01-15.
- [Regulatory] Hypothyroidism. StatPearls [Internet]. National Library of Medicine. Updated 2024. https://www.ncbi.nlm.nih.gov/books/NBK519536/ Accessed 2025-01-15.
- [Regulatory] Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/ Accessed 2025-01-15.
- [Clinical] Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550-1562. https://pubmed.ncbi.nlm.nih.gov/30192760/ Accessed 2025-01-15.
- [Clinical] Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014;35(3):433-512. https://pubmed.ncbi.nlm.nih.gov/33475010/ Accessed 2025-01-15.
- [Clinical] Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. https://pubmed.ncbi.nlm.nih.gov/18341376/ Accessed 2025-01-15.
- [Clinical] Hennessey JV, Espaillat R. Diagnosis and management of subclinical hypothyroidism in elderly adults: a review of the literature. J Am Geriatr Soc. 2015;63(8):1663-1673. https://pubmed.ncbi.nlm.nih.gov/19684048/ Accessed 2025-01-15.
- [Clinical] Flynn RW, Bonellie SR, Jung RT, et al. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures. J Clin Endocrinol Metab. 2010;95(1):186-193. https://pubmed.ncbi.nlm.nih.gov/25554725/ Accessed 2025-01-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: